日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Escherichia coli Glucans biosynthesis protein C (mdoC), partial CSB-YP630112EGW
CSB-EP630112EGW
CSB-BP630112EGW
CSB-MP630112EGW
CSB-EP630112EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Putative aminoacrylate peracid reductase RutC (rutC) CSB-YP630113EGW
CSB-EP630113EGW
CSB-BP630113EGW
CSB-MP630113EGW
CSB-EP630113EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Ribosomal RNA large subunit methyltransferase I (rlmI) CSB-YP630114EGW
CSB-EP630114EGW
CSB-BP630114EGW
CSB-MP630114EGW
CSB-EP630114EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Alkanesulfonate monooxygenase (ssuD) CSB-YP630115EGW
CSB-EP630115EGW
CSB-BP630115EGW
CSB-MP630115EGW
CSB-EP630115EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Lipid A export ATP-binding/permease protein MsbA (msbA), partial CSB-YP630116EGW1
CSB-EP630116EGW1
CSB-BP630116EGW1
CSB-MP630116EGW1
CSB-EP630116EGW1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Translation initiation factor IF-1 (infA) CSB-YP630117EGW
CSB-EP630117EGW
CSB-BP630117EGW
CSB-MP630117EGW
CSB-EP630117EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Ribosomal protein S12 methylthiotransferase RimO (rimO) CSB-YP630118EGW
CSB-EP630118EGW
CSB-BP630118EGW
CSB-MP630118EGW
CSB-EP630118EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli PKHD-type hydroxylase ybiX (ybiX) CSB-YP630119EGW
CSB-EP630119EGW
CSB-BP630119EGW
CSB-MP630119EGW
CSB-EP630119EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Galactokinase (galK) CSB-YP630120EGW
CSB-EP630120EGW
CSB-BP630120EGW
CSB-MP630120EGW
CSB-EP630120EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Glucosamine-6-phosphate deaminase (nagB) CSB-YP630121EGW
CSB-EP630121EGW
CSB-BP630121EGW
CSB-MP630121EGW
CSB-EP630121EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Protein CrcB homolog (crcB), partial CSB-YP630122EGW1
CSB-EP630122EGW1
CSB-BP630122EGW1
CSB-MP630122EGW1
CSB-EP630122EGW1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Bifunctional protein FolD (folD) CSB-YP630123EGW
CSB-EP630123EGW
CSB-BP630123EGW
CSB-MP630123EGW
CSB-EP630123EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Acetyl esterase (aes) CSB-YP630124EGW
CSB-EP630124EGW
CSB-BP630124EGW
CSB-MP630124EGW
CSB-EP630124EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli ATP-dependent Clp protease proteolytic subunit (clpP) CSB-YP630125EGW
CSB-BP630125EGW
CSB-MP630125EGW
CSB-EP630125EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Transcriptional repressor NrdR (nrdR) CSB-YP630126EGW
CSB-EP630126EGW
CSB-BP630126EGW
CSB-MP630126EGW
CSB-EP630126EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Transcriptional repressor frmR (frmR) CSB-YP630127EGW
CSB-EP630127EGW
CSB-BP630127EGW
CSB-MP630127EGW
CSB-EP630127EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Probable HTH-type transcriptional regulator matA homolog (matA) CSB-YP630128EGW
CSB-EP630128EGW
CSB-BP630128EGW
CSB-MP630128EGW
CSB-EP630128EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli DNA polymerase IV (dinB) CSB-YP630129EGW
CSB-EP630129EGW
CSB-BP630129EGW
CSB-MP630129EGW
CSB-EP630129EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase (lpxA) CSB-YP630130EGW
CSB-EP630130EGW
CSB-BP630130EGW
CSB-MP630130EGW
CSB-EP630130EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (dapD) CSB-YP630131EGW
CSB-EP630131EGW
CSB-BP630131EGW
CSB-MP630131EGW
CSB-EP630131EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×